Cell & Gene Therapy
Contract Development and Manufacturing Organisation (CDMO)
Product Development, Launch & Supply
Consulting Services
Enabling healthcare companies to launch and supply products
Cell & Gene Therapy | Pharmaceutical | Biotechnology | Medical Device
Your Commercialisation Journey
Our Clients
2023 ATMP Review
The Advanced Therapeutic Medicinal Products (ATMPs) sector is evolving rapidly and new products have already demonstrated the ability to reverse or significantly impact the progression of disease. In recent years, the advent of cell and gene therapies has shown the...
Cell Therapies: HiTech Health & VascVersa Partnership
HiTech Health is thrilled to announce its partnership with VascVersa, a trailblazer in regenerative medicine focusing on pioneering cell therapies that significantly enhance vascular regeneration and repair. Originating from Queen's University Belfast, VascVersa is a...
HiTech Health, University of Galway and Odyssey Validation Consultants awarded DTIF funding
The Disruptive Technologies Innovation Fund (DTIF) is a €500 million fund established under Ireland’s National Development Plan (NDP) in 2018. On Thursday 23rd November, Ireland’s Minister for Enterprise, Trade and Employment, Simon Coveney TD, Minister for Further...
Telephone
IE: +353-1-9631489
UK: +44-20-30267419
US: +1-857-3265835
Contact us
Get in touch anytime – we are always available to discuss your upcoming projects.